A cautious pricing strategy paid off for TopoTarget A/S, as its initial public offering of 10 million shares on the Copenhagen Stock Exchange, which yielded gross proceeds of DKK225 million (US$36.5 million), was more than six times over-subscribed. (BioWorld International) Read More